11.06.2024 - 13.06.2024Hyatt Centric Fisherman's Wharf San Francisco, 555 North Point Street, 94133 San Francisco, California, USA
Time: 9:00 am to 4:00 pm
Kongressthemen In 2024, age-related disease biotechs are set to shine, building on 2023's milestones such as Eli Lilly's partnership with BioAge to test muscle rejuvenation therapy and Chan Zuckerberg Biolabs tapping into immune cell engineering to eradicate age-related diseases.
To successfully navigate the volatile market of 2024, rapid proof-of-concept studies and validated clinical endpoints are crucial for funding and pipeline progress.
Speakers: Abdulkader Rahmo, President and CSO, SMS Biotech, AndAndrew Butler, Professor, Department of Pharmacology and Physiology, Institute for Translational Neuroscience and more